Delivery Order SPE2DB20D1100-SPE2DB25FE1QY
Award Date 9/29/25
Potential Completion Date 10/21/25
Potential Value $112K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,926.40 to AmerisourceBergen Drug Corp for the supply of Gamunex-C, a 40 gram/400 mL immunoglobulin product, with an ultimate completion date of June 17, 2025. The award, issued May 27, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a delivery order valued at $111,324.90 to AmerisourceBergen Drug Corp for the supply of Gamunex-C 40 gram/400 mL vials on September 29, 2025. This firm fixed price delivery order is scheduled for completion by October 21, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a competitive, non-set-aside basis, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,981.60 to AmerisourceBergen Drug Corp for GAMUNEX-C, a 40-gram/400 milliliter immunoglobulin vial. The contract, issued on August 6, 2025, carries a firm fixed price and is scheduled for completion by August 27, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $9,308.80 to AmerisourceBergen Drug Corp for the supply of Gamunex-C, a 40-gram immunoglobulin product in 400 mL vials, with performance through September 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction within AmerisourceBergen's extensive pharmaceutical supply portfolio supporting federal medical procurement needs. The contract will be performed at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,743.66 to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 20 gram/200 milliliter vials on September 15, 2025, with an ultimate completion date of October 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract involves the delivery of an immunoglobulin...
- The Defense Logistics Agency awarded a delivery order valued at $52,710.86 to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C, a 20-gram/200-milliliter immunoglobulin vial product. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 21, 2025, with performance to be executed at AmerisourceBergen's headquarters facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded a delivery order valued at $28,323.36 to AmerisourceBergen Drug Corp for the supply of Gamunex-C 20 gram/200 mL vials on September 18, 2025, with completion targeted for October 9, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $1 billion through December 2026. The company, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $7,325.64 to AmerisourceBergen Drug Corp for GAMUNEX-C, a 10 gram/100 mL immunoglobulin vial product, with an ultimate completion date of August 21, 2025. This competitive award, issued on July 31, 2025, utilizes a firm fixed price contract type with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $18,314.10 to AmerisourceBergen Drug Corp for the supply of Gamunex-C 10 gram/100 mL vials on August 27, 2025, with an ultimate completion date of September 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The contract will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,162.44 to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Gamunex-C 20 gram/200 mL vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 16, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation and represents a child delivery order under a larger contract vehicle....